Literature DB >> 28894888

[Posttherapeutic changes in bone marrow].

T Geith1, A-C Stellwag2, A Baur-Melnyk2.   

Abstract

The bone marrow basically consists of red blood-forming bone marrow and yellow fat. In the skeleton, there is an age-dependent distribution of these two parts. In the context of medical interventions or therapies, bone marrow changes can occur, whereby the normal bone marrow can basically be replaced by fat, edema, or fibrosis/sclerosis. Here, specific signal intensities and patterns are shown in imaging. After irradiation therapies, edematous changes, hemorrhages, and osteoradionecroses are observed. Likewise, insufficiency fractures, impairment of the growth gaps, or the development of tumors is possible. In patients on dialysis, deposit of protein in the bone marrow is possible in the case of the so-called amyloidosis osteoarthropathy. Postoperative bone marrow edema, insufficiency fractures, or osteonecrosis can be observed after arthroscopy. Changes in the distribution of fat markers and blood-forming bone marrow can be observed after stem cell transplants. In the therapy with cortisone, insufficiency fractures and osteonecroses are possible. Depending on their effect on the hematopoietic system, chemotherapyies can first lead to edematous changes and then to fatty bone marrow, which is reversible after therapy. Angiogenesis inhibitors in combination with other chemotherapeutic agents often lead to mixed images of stimulated and fatty bone marrow.

Entities:  

Keywords:  Angiogenesis inhibitors; Chemotherapy; Dialysis; Radiotherapy; Yellow marrow

Mesh:

Year:  2017        PMID: 28894888     DOI: 10.1007/s00117-017-0300-5

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  19 in total

1.  MRI gadolinium enhancement of bone marrow: age-related changes in normals and in diffuse neoplastic infiltration.

Authors:  A Baur; A Stäbler; R Bartl; R Lamerz; J Scheidler; M Reiser
Journal:  Skeletal Radiol       Date:  1997-07       Impact factor: 2.199

Review 2.  Normal bone marrow: signal characteristics and fatty conversion.

Authors:  P S Babyn; M Ranson; M E McCarville
Journal:  Magn Reson Imaging Clin N Am       Date:  1998-08       Impact factor: 2.266

3.  MRI in the evaluation of late bone marrow changes following bone marrow transplantation.

Authors:  S F Tanner; J Clarke; M O Leach; M H Mesbahi; V Nicolson; R Powles; J E Husband; D Tait
Journal:  Br J Radiol       Date:  1996-12       Impact factor: 3.039

4.  Transient Bone Marrow Edema Syndrome versus Osteonecrosis: Perfusion Patterns at Dynamic Contrast-enhanced MR Imaging with High Temporal Resolution Can Allow Differentiation.

Authors:  Tobias Geith; Thomas Niethammer; Stefan Milz; Olaf Dietrich; Maximilian Reiser; Andrea Baur-Melnyk
Journal:  Radiology       Date:  2016-12-01       Impact factor: 11.105

5.  Antitumor activity of thalidomide in refractory multiple myeloma.

Authors:  S Singhal; J Mehta; R Desikan; D Ayers; P Roberson; P Eddlemon; N Munshi; E Anaissie; C Wilson; M Dhodapkar; J Zeddis; B Barlogie
Journal:  N Engl J Med       Date:  1999-11-18       Impact factor: 91.245

Review 6.  Skeletal complications in pediatric oncology patients.

Authors:  D J Roebuck
Journal:  Radiographics       Date:  1999 Jul-Aug       Impact factor: 5.333

7.  Initial MRI findings of non-traumatic osteonecrosis of the femoral head in renal allograft recipients.

Authors:  T Kubo; S Yamazoe; N Sugano; M Fujioka; S Naruse; N Yoshimura; T Oka; Y Hirasawa
Journal:  Magn Reson Imaging       Date:  1997       Impact factor: 2.546

8.  Iron overload following bone marrow transplantation in children: MR findings.

Authors:  L Kornreich; G Horev; I Yaniv; J Stein; M Grunebaum; R Zaizov
Journal:  Pediatr Radiol       Date:  1997-11

9.  Decrease in tumor apparent permeability-surface area product to a MRI macromolecular contrast medium following angiogenesis inhibition with correlations to cytotoxic drug accumulation.

Authors:  Heike E Daldrup-Link; Yoshitaka Okuhata; Allan Wolfe; Sudesk Srivastav; Sven Øie; Napoleone Ferrara; Robert L Cohen; David M Shames; Robert C Brasch
Journal:  Microcirculation       Date:  2004 Jul-Aug       Impact factor: 2.628

10.  [Risk of Developing Clinical Symptomatically Postmeniscectomy Bone Marrow Edema].

Authors:  M Schmitt-Sody; M Boutsakis; K Bartel; C Valle; A Veihelmann
Journal:  Z Orthop Unfall       Date:  2015-11-20       Impact factor: 0.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.